Initial treatment of CLL: integrating biology and functional status.

Abstract

A better understanding of the biology of chronic lymphocytic leukemia (CLL) has led to significant advances in therapeutic strategies for patients with CLL. Chemoimmunotherapy (CIT) has been the standard first-line therapy for CLL. Age and comorbidities can help decide which patients may benefit from a CIT approach. FCR (fludarabine, cyclophosphamide, and… (More)
DOI: 10.1182/blood-2015-04-585067

Topics

3 Figures and Tables

Cite this paper

@article{Jain2015InitialTO, title={Initial treatment of CLL: integrating biology and functional status.}, author={Nitin Jain and Susan M O'Brien}, journal={Blood}, year={2015}, volume={126 4}, pages={463-70} }